Patent Achievement by Our Faculty Member for Cancer Treatment
As a result of the R&D studies conducted by Istinye University Faculty Member Prof. Dr. Engin Ulukaya, the invention titled “De Novo Antineoplastic Drug Design for the Suppression of Head, Neck, and Oral Cancer” has been granted a patent. Our university continues not only to generate knowledge but also to transform it into value for society and the economy. We congratulate all researchers and academics who contributed to this success, and we proudly share the joy of transforming knowledge into a power that touches lives.
About Prof. Dr. Engin Ulukaya
Prof. Dr. Engin Ulukaya graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1987 and subsequently completed his specialization in Medical Biochemistry at Uludağ University. He earned his PhD at the University of Leeds (UK), School of Biochemistry and Molecular Biology. His research focuses on basic cancer studies, cell death, cancer drug development, and personalized oncology. In addition to serving as the President of the Molecular Cancer Research Association (MOKAD), he is a Council Member of the European Association for Cancer Research (EACR) and a full member of the EORTC PathoBiology Group. He is currently the Director of the Istinye University Molecular Cancer Application and Research Center (İSÜMKAM).
